VR Adviser, LLC
- SEC CIK
- 0001615982
- Latest filing
- Aug 14, 2026
TERN holding history
Terns Pharmaceuticals, Inc. in every 13F filed by VR Adviser, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TERN overviewAll 13F holders of TERNFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −1,077,090−100.0% | Sold out | Holders |
| Q4 2024 | 1,077,090 | $5.97M | 0.4% | −2,332,968−68.4% | Reduced | Holders |
| Q3 2024 | 3,410,058 | $28.4M | 1.5% | 00.0% | Unchanged | Holders |
| Q2 2024 | 3,410,058 | $23.2M | 1.5% | 00.0% | Unchanged | Holders |
| Q1 2024 | 3,410,058 | $22.4M | 1.1% | −1,087,059−24.2% | Reduced | Holders |
| Q4 2023 | 4,497,117 | $29.2M | 2.0% | +1,404,844+45.4% | Added | Holders |
| Q3 2023 | 3,092,273 | $15.6M | 1.6% | +119,404+4.0% | Added | Holders |
| Q2 2023 | 2,972,869 | $26.0M | 4.2% | −646,653−17.9% | Reduced | Holders |
| Q1 2023 | 3,619,522 | $42.9M | 8.4% | −88,369−2.4% | Reduced | Holders |
| Q4 2022 | 3,707,891 | $37.7M | 6.4% | 00.0% | Unchanged | Holders |
| Q3 2022 | 3,707,891 | $21.8M | 3.4% | +3,707,891 | New | Holders |